The multifaceted effects of Alpha1-Antitrypsin on neutrophil functions

Frontiers in Pharmacology

Volumn 9, Issue APR, 2018, Pages

  Janciauskiene, Sabina ^a,b   Wrenger, Sabine ^a   Immenschuh, Stephan ^a   Olejnicka, Beata ^c   Greulich, Timm ^d   Welte, Tobias ^a   Chorostowska Wynimko, Joanna ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b NATIONAL TUBERCULOSIS AND LUNG DISEASES RESEARCH INSTITUTE   (Poland)

^c Trelleborg Hospital   (Sweden)

^d UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

Acute phase protein; Alpha1 Antitrypsin; Cytokines; Inflammation; Innate immunity; Neutrophil degranulation; Neutrophil granulocyte; Proteases

Indexed keywords

ALPHA 1 ANTITRYPSIN; MYELOBLASTIN; SERINE PROTEINASE;

CARCINOGENESIS; CELL DIFFERENTIATION; COMPLEX FORMATION; CONFORMATIONAL TRANSITION; DRUG RESEARCH; ENZYME INHIBITION; HUMAN; LEUKOCYTE ACTIVATION; METASTASIS; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN POLYMORPHISM; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION;

EID: 85045512544     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2018.00341     Document Type: Review

References (169)

1. Afonina, I. S., Muller, C., Martin, S. J., and Beyaert, R. (2015). Proteolytic processing of interleukin-1 family cytokines: variations on a common theme. Immunity 42, 991-1004. doi: 10.1016/j.immuni.2015.06.003
2. Aggarwal, N., Korenbaum, E., Mahadeva, R., Immenschuh, S., Grau, V., Dinarello, C. A., et al. (2016). Alpha-linoleic acid enhances the capacity of alpha-1 antitrypsin to inhibit lipopolysaccharide-induced IL-1beta in human blood neutrophils. Mol. Med. 22, 680-693. doi: 10.2119/molmed.2016.00119
3. Al-Omari, M., Korenbaum, E., Ballmaier, M., Lehmann, U., Jonigk, D., Manstein, D. J., et al. (2011). Acute-phase protein alpha1-antitrypsin inhibits neutrophil calpain I and induces random migration. Mol. Med. 17, 865-874. doi: 10.2119/molmed.2011.00089
4. Arthur, J. S., and Crawford, C. (1996). Investigation of the interaction of m-calpain with phospholipids: calpain-phospholipid interactions. Biochim. Biophys. Acta 1293, 201-206. doi: 10.1016/0167-4838(95)00243-X
5. Beatty, K., Bieth, J., and Travis, J. (1980). Kinetics of association of serine proteinases with native and oxidized alpha-1-proteinase inhibitor and alpha-1-antichymotrypsin. J. Biol. Chem. 255, 3931-3934
6. Befus, A. D., Mowat, C., Gilchrist, M., Hu, J., Solomon, S., and Bateman, A. (1999). Neutrophil defensins induce histamine secretion from mast cells: mechanisms of action. J. Immunol. 163, 947-953
7. Bekes, E. M., Schweighofer, B., Kupriyanova, T. A., Zajac, E., Ardi, V. C., Quigley, J. P., et al. (2011). Tumor-recruited neutrophils and neutrophil TIMP-free MMP-9 regulate coordinately the levels of tumor angiogenesis and efficiency of malignant cell intravasation. Am. J. Pathol. 179, 1455-1470. doi: 10.1016/j.ajpath.2011.05.031
8. Belaaouaj, A., McCarthy, R., Baumann, M., Gao, Z., Ley, T. J., Abraham, S. N., et al. (1998). Mice lacking neutrophil elastase reveal impaired host defense against gram negative bacterial sepsis. Nat. Med. 4, 615-618. doi: 10.1038/nm0598-615
9. Belorgey, D., and Bieth, J. G. (1998). Effect of polynucleotides on the inhibition of neutrophil elastase by mucus proteinase inhibitor and alpha 1-proteinase inhibitor. Biochemistry 37, 16416-16422. doi: 10.1021/bi981536o
10. Bergin, D. A., Reeves, E. P., Hurley, K., Wolfe, R., Jameel, R., Fitzgerald, S., et al. (2014). The circulating proteinase inhibitor alpha-1 antitrypsin regulates neutrophil degranulation and autoimmunity. Sci. Transl. Med. 6:217ra1. doi: 10.1126/scitranslmed.3007116
11. Bergin, D. A., Reeves, E. P., Meleady, P., Henry, M., McElvaney, O. J., Carroll, T. P., et al. (2010). Alpha-1 antitrypsin regulates human neutrophil chemotaxis induced by soluble immune complexes and IL-8. J. Clin. Invest. 120, 4236-4250. doi: 10.1172/JCI41196
12. Blaurock, N., Schmerler, D., Hunniger, K., Kurzai, O., Ludewig, K., Baier, M., et al. (2016). C-terminal alpha-1 antitrypsin peptide: a new sepsis biomarker with immunomodulatory function. Mediat. Inflamm. 2016:6129437. doi: 10.1155/2016/6129437
13. Bradley, L. M., Douglass, M. F., Chatterjee, D., Akira, S., and Baaten, B. J. (2012). Matrix metalloprotease 9 mediates neutrophil migration into the airways in response to influenza virus-induced toll-like receptor signaling. PLoS Pathog. 8:e1002641. doi: 10.1371/journal.ppat.1002641
14. Broemstrup, T., and Reuter, N. (2010). How does proteinase 3 interact with lipid bilayers? Phys. Chem. Chem. Phys. 12, 7487-7496. doi: 10.1039/b924117e
15. Bucurenci, N., Blake, D. R., Chidwick, K., and Winyard, P. G. (1992). Inhibition of neutrophil superoxide production by human plasma alpha 1-antitrypsin. FEBS Lett. 300, 21-24. doi: 10.1016/0014-5793(92)80156-B
16. Caccavo, D., Rigon, A., Picardi, A., Galluzzo, S., Vadacca, M., Ferri, G. M., et al. (2005). Anti-lactoferrin antibodies in systemic lupus erythematosus: isotypes and clinical correlates. Clin. Rheumatol. 24, 381-387. doi: 10.1007/s10067-004-1040-2
17. Campbell, E. J., Campbell, M. A., and Owen, C. A. (2000). Bioactive proteinase 3 on the cell surface of human neutrophils: quantification, catalytic activity, and susceptibility to inhibition. J. Immunol. 165, 3366-3374. doi: 10.4049/jimmunol.165.6.3366
18. Carney, D. F., Jagels, M. A., Hugli, T. E., Sands, H., and Rubin, H. (1998). Effect of serine proteinase inhibitors on neutrophil function: alpha-1-proteinase inhibitor, antichymotrypsin, and a recombinant hybrid mutant of antichymotrypsin (LEX032) modulate neutrophil adhesion interactions. J. Leukoc. Biol. 63, 75-82. doi: 10.1002/jlb.63.1.75
19. Carrell, R. W., Jeppsson, J. O., Vaughan, L., Brennan, S. O., Owen, M. C., and Boswell, D. R. (1981). Human alpha 1-antitrypsin: carbohydrate attachment and sequence homology. FEBS Lett. 135, 301-303. doi: 10.1016/0014-5793(81)80805-8
20. Carvalho, M. O. S., Souza, A., Carvalho, M. B., Pacheco, A., Rocha, L. C., do Nascimento, V. M. L., et al. (2017). Evaluation of alpha-1 antitrypsin levels and SERPINA1 gene polymorphisms in sickle cell disease. Front. Immunol. 8:1491. doi: 10.3389/fimmu.2017.01491
21. Chang, Y. P., Mahadeva, R., Patschull, A. O., Nobeli, I., Ekeowa, U. I., McKay, A. R., et al. (2011). Targeting serpins in high-throughput and structure-based drug design. Methods Enzymol. 501, 139-175. doi: 10.1016/B978-0-12-385950-1.00008-0
22. Chikazawa, H., Nishiya, K., Matsumori, A., and Hashimoto, K. (2000). Immunoglobulin isotypes of anti-myeloperoxidase and anti-lactoferrin antibodies in patients with collagen diseases. J. Clin. Immunol. 20, 279-286. doi: 10.1023/A:1006667703202
23. Clemmensen, S. N., Jacobsen, L. C., Rorvig, S., Askaa, B., Christenson, K., Iversen, M., et al. (2011). Alpha-1-antitrypsin is produced by human neutrophil granulocytes and their precursors and liberated during granule exocytosis. Eur. J. Haematol. 86, 517-530. doi: 10.1111/j.1600-0609.2011.01601.x
24. Coeshott, C., Ohnemus, C., Pilyavskaya, A., Ross, S., Wieczorek, M., Kroona, H., et al. (1999). Converting enzyme-independent release of tumor necrosis factor alpha and IL-1beta from a stimulated human monocytic cell line in the presence of activated neutrophils or purified proteinase 3. Proc. Natl. Acad. Sci. U.S.A. 96, 6261-6266. doi: 10.1073/pnas.96.11.6261
25. Coffelt, S. B., Wellenstein, M. D., and de Visser, K. E. (2016). Neutrophils in cancer: neutral no more. Nat. Rev. Cancer 16, 431-446. doi: 10.1038/nrc.2016.52
26. Cosgrove, S., Chotirmall, S. H., Greene, C. M., and McElvaney, N. G. (2011). Pulmonary proteases in the cystic fibrosis lung induce interleukin 8 expression from bronchial epithelial cells via a heme/meprin/epidermal growth factor receptor/Toll-like receptor pathway. J. Biol. Chem. 286, 7692-7704. doi: 10.1074/jbc. M110.183863
27. Csernok, E., Ludemann, J., Gross, W. L., and Bainton, D. F. (1990). Ultrastructural localization of proteinase 3, the target antigen of anti-cytoplasmic antibodies circulating in Wegener's granulomatosis. Am. J. Pathol. 137, 1113-1120
28. David, A., Fridlich, R., and Aviram, I. (2005). The presence of membrane proteinase 3 in neutrophil lipid rafts and its colocalization with FcgammaRIIIb and cytochrome b558. Exp. Cell Res. 308, 156-165. doi: 10.1016/j.yexcr.2005.03.034
29. Delgado-Rizo, V., Martinez-Guzman, M. A., Iniguez-Gutierrez, L., Garcia-Orozco, A., Alvarado-Navarro, A., and Fafutis-Morris, M. (2017). Neutrophil extracellular traps and its implications in inflammation: an overview. Front. Immunol. 8:81. doi: 10.3389/fimmu.2017.00081
30. Dementiev, A., Simonovic, M., Volz, K., and Gettins, P. G. (2003). Canonical inhibitor-like interactions explain reactivity of alpha1-proteinase inhibitor Pittsburgh and antithrombin with proteinases. J. Biol. Chem. 278, 37881-37887. doi: 10.1074/jbc. M305195200
31. Devaney, J. M., Greene, C. M., Taggart, C. C., Carroll, T. P., O'Neill, S. J., and McElvaney, N. G. (2003). Neutrophil elastase up-regulates interleukin-8 via toll-like receptor 4. FEBS Lett. 544, 129-132. doi: 10.1016/S0014-5793(03)00482-4
32. Donskov, F. (2013). Immunomonitoring and prognostic relevance of neutrophils in clinical trials. Semin. Cancer Biol. 23, 200-207. doi: 10.1016/j.semcancer.2013.02.001
33. Duranton, J., Boudier, C., Belorgey, D., Mellet, P., and Bieth, J. G. (2000). DNA strongly impairs the inhibition of cathepsin G by alpha(1)-antichymotrypsin and alpha(1)-proteinase inhibitor. J. Biol. Chem. 275, 3787-3792. doi: 10.1074/jbc.275.6.3787
34. Ehlers, M. R. (2014). Immune-modulating effects of alpha-1 antitrypsin. Biol. Chem. 395, 1187-1193. doi: 10.1515/hsz-2014-0161
35. Elliott, P. R., Lomas, D. A., Carrell, R. W., and Abrahams, J. P. (1996). Inhibitory conformation of the reactive loop of alpha 1-antitrypsin. Nat. Struct. Biol. 3, 676-681. doi: 10.1038/nsb0896-676
36. Ermolieff, J., Boudier, C., Laine, A., Meyer, B., and Bieth, J. G. (1994). Heparin protects cathepsin G against inhibition by protein proteinase inhibitors. J. Biol. Chem. 269, 29502-29508
37. Fadini, G. P., Menegazzo, L., Rigato, M., Scattolini, V., Poncina, N., Bruttocao, A., et al. (2016). NETosis delays diabetic wound healing in mice and humans. Diabetes Metab. Res. Rev. 65, 1061-1071. doi: 10.2337/db15-0863
38. Faller, B., Cadene, M., and Bieth, J. G. (1993). Demonstration of a two-step reaction mechanism for the inhibition of heparin-bound neutrophil elastase by alpha 1-proteinase inhibitor. Biochemistry 32, 9230-9235. doi: 10.1021/bi00086a031
39. Ferry, G., Lonchampt, M., Pennel, L., de Nanteuil, G., Canet, E., and Tucker, G. C. (1997). Activation of MMP-9 by neutrophil elastase in an in vivo model of acute lung injury. FEBS Lett. 402, 111-115. doi: 10.1016/S0014-5793(96)01508-6
40. Fiedler, M. A., Wernke-Dollries, K., and Stark, J. M. (1998). Inhibition of TNF-alpha-induced NF-kappaB activation and IL-8 release in A549 cells with the proteasome inhibitor MG-132. Am. J. Respir. Cell Mol. Biol. 19, 259-268. doi: 10.1165/ajrcmb.19.2.3149
41. Frenzel, E., Korenbaum, E., Hegermann, J., Ochs, M., Koepke, J., Koczulla, A. R., et al. (2012). Does augmentation with alpha1-antitrypsin affect neutrophil extracellular traps formation? Int. J. Biol. Sci. 8, 1023-1025. doi: 10.7150/ijbs.4701
42. Frenzel, E., Wrenger, S., Brugger, B., Salipalli, S., Immenschuh, S., Aggarwal, N., et al. (2015). Alpha1-antitrypsin combines with plasma fatty acids and induces angiopoietin-like protein 4 expression. J. Immunol. 195, 3605-3616. doi: 10.4049/jimmunol.1500740
43. Fridlender, Z. G., Sun, J., Kim, S., Kapoor, V., Cheng, G., Ling, L., et al. (2009). Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN. Cancer Cell 16, 183-194. doi: 10.1016/j.ccr.2009.06.017
44. Fridlich, R., David, A., and Aviram, I. (2006). Membrane proteinase 3 and its interactions within microdomains of neutrophil membranes. J. Cell Biochem. 99, 117-125. doi: 10.1002/jcb.20901
45. Frommherz, K., and Bieth, J. G. (1991). Effect of sulfated glycosaminoglycans on the inhibition of neutrophil elastase by alpha 1-proteinase inhibitor. Adv. Exp. Med. Biol. 297, 161-165. doi: 10.1007/978-1-4899-3629-5_14
46. Frommherz, K. J., Faller, B., and Bieth, J. G. (1991). Heparin strongly decreases the rate of inhibition of neutrophil elastase by alpha 1-proteinase inhibitor. J. Biol. Chem. 266, 15356-15362
47. Gabay, C., and Kushner, I. (1999). Acute-phase proteins and other systemic responses to inflammation. N. Engl. J. Med. 340, 448-454. doi: 10.1056/NEJM199902113400607
48. Gettins, P. G. (2002). Serpin structure, mechanism, and function. Chem. Rev. 102, 4751-4804
49. Ghaedi, M., Soleimani, M., Taghvaie, N. M., Sheikhfatollahi, M., Azadmanesh, K., Lotfi, A. S., et al. (2011). Mesenchymal stem cells as vehicles for targeted delivery of anti-angiogenic protein to solid tumors. J. Gene Med. 13, 171-180. doi: 10.1002/jgm.1552
50. Goldmann, W. H., Niles, J. L., and Arnaout, M. A. (1999). Interaction of purified human proteinase 3 (PR3) with reconstituted lipid bilayers. Eur. J. Biochem. 261, 155-162. doi: 10.1046/j.1432-1327.1999.00259.x
51. Granick, J. L., Falahee, P. C., Dahmubed, D., Borjesson, D. L., Miller, L. S., and Simon, S. I. (2013). Staphylococcus aureus recognition by hematopoietic stem and progenitor cells via TLR2/MyD88/PGE2 stimulates granulopoiesis in wounds. Blood 122, 1770-1778. doi: 10.1182/blood-2012-11-466268
52. Guyot, N., Wartelle, J., Malleret, L., Todorov, A. A., Devouassoux, G., Pacheco, Y., et al. (2014). Unopposed cathepsin G, neutrophil elastase, and proteinase 3 cause severe lung damage and emphysema. Am. J. Pathol. 184, 2197-2210. doi: 10.1016/j.ajpath.2014.04.015
53. Hajjar, E., Broemstrup, T., Kantari, C., Witko-Sarsat, V., and Reuter, N. (2010). Structures of human proteinase 3 and neutrophil elastase-so similar yet so different. FEBS J. 277, 2238-2254. doi: 10.1111/j.1742-4658.2010.07659.x
54. Hajjar, E., Mihajlovic, M., Witko-Sarsat, V., Lazaridis, T., and Reuter, N. (2008). Computational prediction of the binding site of proteinase 3 to the plasma membrane. Proteins 71, 1655-1669. doi: 10.1002/prot.21853
55. Halbwachs-Mecarelli, L., Bessou, G., Lesavre, P., Lopez, S., and Witko-Sarsat, V. (1995). Bimodal distribution of proteinase 3 (PR3) surface expression reflects a constitutive heterogeneity in the polymorphonuclear neutrophil pool. FEBS Lett. 374, 29-33. doi: 10.1016/0014-5793(95)01073-N
56. Hartl, D., Latzin, P., Hordijk, P., Marcos, V., Rudolph, C., Woischnik, M., et al. (2007). Cleavage of CXCR1 on neutrophils disables bacterial killing in cystic fibrosis lung disease. Nat. Med. 13, 1423-1430. doi: 10.1038/nm1690
57. Higashiyama, M., Doi, O., Kodama, K., Yokouchi, H., and Tateishi, R. (1992). An evaluation of the prognostic significance of alpha-1-antitrypsin expression in adenocarcinomas of the lung: an immunohistochemical analysis. Br. J. Cancer 65, 300-302. doi: 10.1038/bjc.1992.60
58. Houghton, A. M., Rzymkiewicz, D. M., Ji, H., Gregory, A. D., Egea, E. E., Metz, H. E., et al. (2010). Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth. Nat. Med. 16, 219-223. doi: 10.1038/nm.2084
59. Huang, H., Campbell, S. C., Nelius, T., Bedford, D. F., Veliceasa, D., Bouck, N. P., et al. (2004). Alpha1-antitrypsin inhibits angiogenesis and tumor growth. Int. J. Cancer 112, 1042-1048. doi: 10.1002/ijc.20494
60. Hurley, K., Lacey, N., O'Dwyer, C. A., Bergin, D. A., McElvaney, O. J., O'Brien, M. E., et al. (2014). Alpha-1 antitrypsin augmentation therapy corrects accelerated neutrophil apoptosis in deficient individuals. J. Immunol. 193, 3978-3991. doi: 10.4049/jimmunol.1400132
61. Hutchison, D. C. S. (1973). Alpha-1-antitrypsin deficiency and pulmonary emphysema: the role of proteolytic enzymes and their inhibitors. Br. J. Dis. Chest 67, 171-196. doi: 10.1016/0007-0971(73)90053-3
62. Ilie, M. I., Hofman, V., Ortholan, C., Ammadi, R. E., Bonnetaud, C., Havet, K., et al. (2011). Overexpression of carbonic anhydrase XII in tissues from resectable non-small cell lung cancers is a biomarker of good prognosis. Int. J. Cancer 128, 1614-1623. doi: 10.1002/ijc.25491
63. Janciauskiene, S., Dominaitiene, R., Sternby, N. H., Piitulainen, E., and Eriksson, S. (2002). Detection of circulating and endothelial cell polymers of Z and wild type alpha 1-antitrypsin by a monoclonal antibody. J. Biol. Chem. 277, 26540-26546. doi: 10.1074/jbc. M203832200
64. Janciauskiene, S., Tumpara, S., Wiese, M., Wrenger, S., Vijayan, V., Gueler, F., et al. (2017). Alpha1-antitrypsin binds hemin and prevents oxidative activation of human neutrophils: putative pathophysiological significance. J. Leukoc. Biol. 102, 1127-1141. doi: 10.1189/jlb.3A0317-124R
65. Janciauskiene, S., and Welte, T. (2016). Well-known and less well-known functions of alpha-1 antitrypsin. Its role in chronic obstructive pulmonary disease and other disease developments. Ann. Am. Thorac. Soc. 13(Suppl. 4), S280-S288. doi: 10.1513/AnnalsATS.201507-468KV
66. Janciauskiene, S., Zelvyte, I., Jansson, L., and Stevens, T. (2004). Divergent effects of alpha1-antitrypsin on neutrophil activation, in vitro. Biochem. Biophys. Res. Commun. 315, 288-296. doi: 10.1016/j.bbrc.2004.01.055
67. Jensen, H. K., Donskov, F., Marcussen, N., Nordsmark, M., Lundbeck, F., and von der Maase, H. (2009). Presence of intratumoral neutrophils is an independent prognostic factor in localized renal cell carcinoma. J. Clin. Oncol. 27, 4709-4717. doi: 10.1200/JCO.2008.18.9498
68. Johansson, B., Malm, J., Persson, T., Janciauskiene, S., Andersson, P., Carlson, J., et al. (2001). Alpha-1-antitrypsin is present in the specific granules of human eosinophilic granulocytes. Clin. Exp. Allergy 31, 379-386. doi: 10.1046/j.1365-2222.2001.01017.x
69. Johnson, D., and Travis, J. (1979). The oxidative inactivation of human alpha-1-proteinase inhibitor. Further evidence for methionine at the reactive center. J. Biol. Chem. 254, 4022-4026
70. Jonigk, D., Al-Omari, M., Maegel, L., Muller, M., Izykowski, N., Hong, J., et al. (2013). Anti-inflammatory and immunomodulatory properties of alpha1-antitrypsin without inhibition of elastase. Proc. Natl. Acad. Sci. U.S.A. 110, 15007-15012. doi: 10.1073/pnas.1309648110
71. Karnaukhova, E., Krupnikova, S. S., Rajabi, M., and Alayash, A. I. (2012). Heme binding to human alpha-1 proteinase inhibitor. Biochim. Biophys. Acta 1820, 2020-2029. doi: 10.1016/j.bbagen.2012.09.012
72. Kataoka, H., Uchino, H., Iwamura, T., Seiki, M., Nabeshima, K., and Koono, M. (1999). Enhanced tumor growth and invasiveness in vivo by a carboxyl-terminal fragment of alpha1-proteinase inhibitor generated by matrix metalloproteinases: a possible modulatory role in natural killer cytotoxicity. Am. J. Pathol. 154, 457-468. doi: 10.1016/S0002-9440(10)65292-3
73. Katsube, M., Kato, T., Kitagawa, M., Noma, H., Fujita, H., and Kitagawa, S. (2008). Calpain-mediated regulation of the distinct signaling pathways and cell migration in human neutrophils. J. Leukoc. Biol. 84, 255-263. doi: 10.1189/jlb.0907664
74. Kessenbrock, K., Dau, T., and Jenne, D. E. (2011). Tailor-made inflammation: how neutrophil serine proteases modulate the inflammatory response. J. Mol. Med. 89, 23-28. doi: 10.1007/s00109-010-0677-3
75. Koepke, J., Dresel, M., Schmid, S., Greulich, T., Beutel, B., Schmeck, B., et al. (2015). Therapy with plasma purified alpha1-antitrypsin (Prolastin(R)) induces time-dependent changes in plasma levels of MMP-9 and MPO. PLoS One 10:e0117497. doi: 10.1371/journal.pone.0117497
76. Korkmaz, B., Attucci, S., Jourdan, M. L., Juliano, L., and Gauthier, F. (2005). Inhibition of neutrophil elastase by alpha1-protease inhibitor at the surface of human polymorphonuclear neutrophils. J. Immunol. 175, 3329-3338. doi: 10.4049/jimmunol.175.5.3329
77. Korkmaz, B., Attucci, S., Moreau, T., Godat, E., Juliano, L., and Gauthier, F. (2004). Design and use of highly specific substrates of neutrophil elastase and proteinase 3. Am. J. Respir. Cell Mol. Biol. 30, 801-807. doi: 10.1165/rcmb.2003-0139OC
78. Korkmaz, B., Jaillet, J., Jourdan, M. L., Gauthier, A., Gauthier, F., and Attucci, S. (2009). Catalytic activity and inhibition of Wegener antigen proteinase 3 on the cell surface of human polymorphonuclear neutrophils. J. Biol. Chem. 284, 19896-19902. doi: 10.1074/jbc. M901471200
79. Korkmaz, B., Kuhl, A., Bayat, B., Santoso, S., and Jenne, D. E. (2008). A hydrophobic patch on proteinase 3, the target of autoantibodies in Wegener granulomatosis, mediates membrane binding via NB1 receptors. J. Biol. Chem. 283, 35976-35982. doi: 10.1074/jbc. M806754200
80. Laurell, C. B., and Eriksson, S. (1963). The electrophoretic a;1-globulin pattern of serum in a;1-antitrypsin deficiency. Scand. J. Clin. Lab. Invest. 15, 132-140. doi: 10.1080/00365516309051324
81. Lechner, M. G., Liebertz, D. J., and Epstein, A. L. (2010). Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells. J. Immunol. 185, 2273-2284. doi: 10.4049/jimmunol.1000901
82. Lerman, I., and Hammes, S. R. (2017). Neutrophil elastase in the tumor microenvironment. Steroids 133, 96-101. doi: 10.1016/j.steroids.2017.11.006
83. Lewis, E. C. (2012). Expanding the clinical indications for alpha(1)-antitrypsin therapy. Mol. Med. 18, 957-970. doi: 10.2119/molmed.2011.00196
84. Lewis, E. C., Mizrahi, M., Toledano, M., Defelice, N., Wright, J. L., Churg, A., et al. (2008). Alpha1-antitrypsin monotherapy induces immune tolerance during islet allograft transplantation in mice. Proc. Natl. Acad. Sci. U.S.A. 105, 16236-16241. doi: 10.1073/pnas.0807627105
85. Li, Y. W., Qiu, S. J., Fan, J., Zhou, J., Gao, Q., Xiao, Y. S., et al. (2011). Intratumoral neutrophils: a poor prognostic factor for hepatocellular carcinoma following resection. J. Hepatol. 54, 497-505. doi: 10.1016/j.jhep.2010.07.044
86. Li, Z., Alam, S., Wang, J., Sandstrom, C. S., Janciauskiene, S., and Mahadeva, R. (2009). Oxidized α1-antitrypsin stimulates the release of monocyte chemotactic protein-1 from lung epithelial cells: potential role in emphysema. Am. J. Physiol. Lung Cell Mol. Physiol. 297, L388-L400. doi: 10.1152/ajplung.90373.2008
87. Liu, Z., Zhou, X., Shapiro, S. D., Shipley, J. M., Twining, S. S., Diaz, L. A., et al. (2000). The serpin alpha1-proteinase inhibitor is a critical substrate for gelatinase B/MMP-9 in vivo. Cell 102, 647-655. doi: 10.1016/S0092-8674(00)00087-8
88. Loison, F., Zhu, H., Karatepe, K., Kasorn, A., Liu, P., Ye, K., et al. (2014). Proteinase 3-dependent caspase-3 cleavage modulates neutrophil death and inflammation. J. Clin. Invest. 124, 4445-4458. doi: 10.1172/JCI76246
89. Lokuta, M. A., Nuzzi, P. A., and Huttenlocher, A. (2003). Calpain regulates neutrophil chemotaxis. Proc. Natl. Acad. Sci. U.S.A. 100, 4006-4011. doi: 10.1073/pnas.0636533100
90. Long, G. L., Chandra, T., Woo, S. L. C., Davie, E. W., and Kurachi, K. (1984). Complete sequence of the cDNA for human alpha 1-antitrypsin and the gene for the S variant. Biochemistry 23, 4828-4837. doi: 10.1021/bi00316a003
91. Luo, H. R., and Loison, F. (2008). Constitutive neutrophil apoptosis: mechanisms and regulation. Am. J. Hematol. 83, 288-295. doi: 10.1002/ajh.21078
92. Mahadeva, R., Atkinson, C., Li, Z., Stewart, S., Janciauskiene, S., Kelley, D. G., et al. (2005). Polymers of Z alpha1-antitrypsin co-localize with neutrophils in emphysematous alveoli and are chemotactic in vivo. Am. J. Pathol. 166, 377-386. doi: 10.1016/S0002-9440(10)62261-4
93. Malerba, M., Ricciardolo, F., Radaeli, A., Torregiani, C., Ceriani, L., Mori, E., et al. (2006). Neutrophilic inflammation and IL-8 levels in induced sputum of alpha-1-antitrypsin PiMZ subjects. Thorax 61, 129-133. doi: 10.1136/thx.2005.043471
94. Mantovani, A., Cassatella, M. A., Costantini, C., and Jaillon, S. (2011). Neutrophils in the activation and regulation of innate and adaptive immunity. Nat. Rev. Immunol. 11, 519-531. doi: 10.1038/nri3024
95. Mason, D. Y., Cramer, E. M., Masse, J. M., Crystal, R., Bassot, J. M., and Breton-Gorius, J. (1991). Alpha 1-antitrypsin is present within the primary granules of human polymorphonuclear leukocytes. Am. J. Pathol. 139, 623-628
96. Matamala, N., Aggarwal, N., Iadarola, P., Fumagalli, M., Gomez-Mariano, G., Lara, B., et al. (2017). Identification of novel short C-terminal transcripts of human SERPINA1 gene. PLoS One 12:e0170533. doi: 10.1371/journal.pone.0170533
97. Mayadas, T. N., Cullere, X., and Lowell, C. A. (2014). The multifaceted functions of neutrophils. Annu. Rev. Pathol. 9, 181-218. doi: 10.1146/annurev-pathol-020712-164023
98. McCarthy, C., Reeves, E. P., and McElvaney, N. G. (2016). The role of neutrophils in alpha-1 antitrypsin deficiency. Ann. Am. Thorac. Soc. 13(Suppl. 4), S297-S304. doi: 10.1513/AnnalsATS.201509-634KV
99. McElvaney, N. G. (2016). Alpha-1 antitrypsin therapy in cystic fibrosis and the lung disease associated with alpha-1 antitrypsin deficiency. Ann. Am. Thorac. Soc. 13(Suppl. 2), S191-S196. doi: 10.1513/AnnalsATS.201504-245KV
100. Mega, T., Lujan, E., and Yoshida, A. (1980). Studies on the oligosaccharide chains of human alpha 1-protease inhibitor. II. Structure of oligosaccharides. J. Biol. Chem. 255, 4057-4061
101. Michaelis, J., Vissers, M. C., and Winterbourn, C. C. (1992). Cleavage of alpha 1-antitrypsin by human neutrophil collagenase. Matrix Suppl. 1, 80-81
102. Monk, R., Graves, M., Williams, P., and Strange, C. (2013). Inhaled alpha 1-antitrypsin: gauging patient interest in a new treatment. COPD 10, 411-415. doi: 10.3109/15412555.2012.758698
103. Moreno, J. A., Ortega-Gomez, A., Rubio-Navarro, A., Louedec, L., Ho-Tin-Noe, B., Caligiuri, G., et al. (2014). High-density lipoproteins potentiate alpha1-antitrypsin therapy in elastase-induced pulmonary emphysema. Am. J. Respir. Cell Mol. Biol. 51, 536-549. doi: 10.1165/rcmb.2013-0103OC
104. Mueller, C., and Flotte, T. R. (2013). Gene-based therapy for alpha-1 antitrypsin deficiency. COPD 10(Suppl. 1), 44-49. doi: 10.3109/15412555.2013.764978
105. Mulgrew, A. T., Taggart, C. C., Lawless, M. W., Greene, C. M., Brantly, M. L., O'Neill, S. J., et al. (2004). Z alpha1-antitrypsin polymerizes in the lung and acts as a neutrophil chemoattractant. Chest 125, 1952-1957. doi: 10.1378/chest.125.5.1952
106. Na, S., Paek, E., Choi, J. S., Kim, D., Lee, S. J., and Kwon, J. (2015). Characterization of disulfide bonds by planned digestion and tandem mass spectrometry. Mol. Biosyst. 11, 1156-1164. doi: 10.1039/c4mb00688g
107. Narasaraju, T., Yang, E., Samy, R. P., Ng, H. H., Poh, W. P., Liew, A. A., et al. (2011). Excessive neutrophils and neutrophil extracellular traps contribute to acute lung injury of influenza pneumonitis. Am. J. Pathol. 179, 199-210. doi: 10.1016/j.ajpath.2011.03.013
108. Nita, I., Hollander, C., Westin, U., and Janciauskiene, S. M. (2005). Prolastin, a pharmaceutical preparation of purified human alpha1-antitrypsin, blocks endotoxin-mediated cytokine release. Respir. Res. 6:12. doi: 10.1186/1465-9921-6-12
109. Nyon, M. P., and Gooptu, B. (2014). Therapeutic targeting of misfolding and conformational change in alpha1-antitrypsin deficiency. Future Med. Chem. 6, 1047-1065. doi: 10.4155/fmc.14.58
110. O'Dwyer, C. A., O'Brien, M. E., Wormald, M. R., White, M. M., Banville, N., Hurley, K., et al. (2015). The BLT1 inhibitory function of alpha-1 antitrypsin augmentation therapy disrupts leukotriene B4 neutrophil signaling. J. Immunol. 195, 3628-3641. doi: 10.4049/jimmunol.1500038
111. Omachi, T. A., Eisner, M. D., Rames, A., Markovtsova, L., and Blanc, P. D. (2011). Matrix metalloproteinase-9 predicts pulmonary status declines in alpha1-antitrypsin deficiency. Respir. Res. 12:35. doi: 10.1186/1465-9921-12-35
112. Opdenakker, G., Fibbe, W. E., and Van Damme, J. (1998). The molecular basis of leukocytosis. Immunol. Today 19, 182-189. doi: 10.1016/S0167-5699(97)01243-7
113. Owen, C. A., and Campbell, E. J. (1999). The cell biology of leukocyte-mediated proteolysis. J. Leukoc. Biol. 65, 137-150. doi: 10.1002/jlb.65.2.137
114. Paakko, P., Kirby, M., du Bois, R. M., Gillissen, A., Ferrans, V. J., and Crystal, R. G. (1996). Activated neutrophils secrete stored alpha 1-antitrypsin. Am. J. Respir. Crit. Care Med. 154, 1829-1833. doi: 10.1164/ajrccm.154.6.8970377
115. Padrines, M., Wolf, M., Walz, A., and Baggiolini, M. (1994). Interleukin-8 processing by neutrophil elastase, cathepsin G and proteinase-3. FEBS Lett. 352, 231-235. doi: 10.1016/0014-5793(94)00952-X
116. Pankov, R., Endo, Y., Even-Ram, S., Araki, M., Clark, K., Cukierman, E., et al. (2005). A Rac switch regulates random versus directionally persistent cell migration. J. Cell Biol. 170, 793-802. doi: 10.1083/jcb.200503152
117. Panyutich, A. V., Hiemstra, P. S., van Wetering, S., and Ganz, T. (1995). Human neutrophil defensin and serpins form complexes and inactivate each other. Am. J. Respir. Cell Mol. Biol. 12, 351-357. doi: 10.1165/ajrcmb.12.3.7873202
118. Parmar, J. S., Mahadeva, R., Reed, B. J., Farahi, N., Cadwallader, K. A., Keogan, M. T., et al. (2002). Polymers of alpha(1)-antitrypsin are chemotactic for human neutrophils: a new paradigm for the pathogenesis of emphysema. Am. J. Respir. Cell Mol. Biol. 26, 723-730. doi: 10.1165/ajrcmb.26.6.4739
119. Paunel-Gorgulu, A., Kirichevska, T., Logters, T., Windolf, J., and Flohe, S. (2012). Molecular mechanisms underlying delayed apoptosis in neutrophils from multiple trauma patients with and without sepsis. Mol. Med. 18, 325-335. doi: 10.2119/molmed.2011.00380
120. Pei, D., Majmudar, G., and Weiss, S. J. (1994). Hydrolytic inactivation of a breast carcinoma cell-derived serpin by human stromelysin-3. J. Biol. Chem. 269, 25849-25855
121. Persson, C., Subramaniyam, D., Stevens, T., and Janciauskiene, S. (2006). Do native and polymeric alpha1-antitrypsin activate human neutrophils in vitro? Chest 129, 1683-1692. doi: 10.1378/chest.129.6.1683
122. Petrache, I., Fijalkowska, I., Medler, T. R., Skirball, J., Cruz, P., Zhen, L., et al. (2006). Alpha-1 antitrypsin inhibits caspase-3 activity, preventing lung endothelial cell apoptosis. Am. J. Pathol. 169, 1155-1166. doi: 10.2353/ajpath.2006.060058
123. Pontremoli, S., Melloni, E., Sparatore, B., Salamino, F., Michetti, M., Sacco, O., et al. (1985). Role of phospholipids in the activation of the Ca2+-dependent neutral proteinase of human erythrocytes. Biochem. Biophys. Res. Commun. 129, 389-395. doi: 10.1016/0006-291X(85)90163-9
124. Price, L. S., Langeslag, M., ten Klooster, J. P., Hordijk, P. L., Jalink, K., and Collard, J. G. (2003). Calcium signaling regulates translocation and activation of Rac. J. Biol. Chem. 278, 39413-39421. doi: 10.1074/jbc. M302083200
125. Rahaghi, F. F., Sandhaus, R. A., Brantly, M. L., Rouhani, F., Campos, M. A., Strange, C., et al. (2012). The prevalence of alpha-1 antitrypsin deficiency among patients found to have airflow obstruction. COPD 9, 352-358. doi: 10.3109/15412555.2012.669433
126. Ralston, D. R., Marsh, C. B., Lowe, M. P., and Wewers, M. D. (1997). Antineutrophil cytoplasmic antibodies induce monocyte IL-8 release. Role of surface proteinase-3, alpha1-antitrypsin, and Fcgamma receptors. J. Clin. Invest. 100, 1416-1424. doi: 10.1172/JCI119662
127. Rao, H. L., Chen, J. W., Li, M., Xiao, Y. B., Fu, J., Zeng, Y. X., et al. (2012). Increased intratumoral neutrophil in colorectal carcinomas correlates closely with malignant phenotype and predicts patients' adverse prognosis. PLoS One 7:e30806. doi: 10.1371/journal.pone.0030806
128. Rao, N. V., Wehner, N. G., Marshall, B. C., Gray, W. R., Gray, B. H., and Hoidal, J. R. (1991). Characterization of proteinase-3 (PR-3), a neutrophil serine proteinase. Structural and functional properties. J. Biol. Chem. 266, 9540-9548
129. Reeves, E. P., Lu, H., Jacobs, H. L., Messina, C. G., Bolsover, S., Gabella, G., et al. (2002). Killing activity of neutrophils is mediated through activation of proteases by K+ flux. Nature 416, 291-297. doi: 10.1038/416291a
130. Robache-Gallea, S., Morand, V., Bruneau, J. M., Schoot, B., Tagat, E., Realo, E., et al. (1995). In vitro processing of human tumor necrosis factor-alpha. J. Biol. Chem. 270, 23688-23692. doi: 10.1074/jbc.270.40.23688
131. Ronzoni, R., Berardelli, R., Medicina, D., Sitia, R., Gooptu, B., and Fra, A. M. (2016). Aberrant disulphide bonding contributes to the ER retention of alpha1-antitrypsin deficiency variants. Hum. Mol. Genet. 25, 642-650. doi: 10.1093/hmg/ddv501
132. Rooney, C. P., Taggart, C., Coakley, R., McElvaney, N. G., and O'Neill, S. J. (2001). Anti-proteinase 3 antibody activation of neutrophils can be inhibited by alpha1-antitrypsin. Am. J. Respir. Cell Mol. Biol. 24, 747-754. doi: 10.1165/ajrcmb.24.6.4147
133. Roozendaal, C., Horst, G., Pogany, K., van Milligen de Wit, A. W., Kleibeuker, J. H., Haagsma, E. B., et al. (1998). Prevalence and clinical significance of anti-lactoferrin autoantibodies in inflammatory bowel diseases and primary sclerosing cholangitis. Adv. Exp. Med. Biol. 443, 313-319. doi: 10.1007/978-1-4757-9068-9_39
134. Rosenberg, S., Barr, P. J., Najarian, R. C., and Hallewell, R. A. (1984). Synthesis in yeast of a functional oxidation-resistant mutant of human alpha-antitrypsin. Nature 312, 77-80. doi: 10.1038/312077a0
135. Sander, L. E., Sackett, S. D., Dierssen, U., Beraza, N., Linke, R. P., Muller, M., et al. (2010). Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function. J. Exp. Med. 207, 1453-1464. doi: 10.1084/jem.20091474
136. Sarabhai, T., Peter, C., Bar, A. K., Windolf, J., Relja, B., Wesselborg, S., et al. (2017). Serum alpha-1 Antitrypsin (AAT) antagonizes intrinsic apoptosis induction in neutrophils from patients with systemic inflammatory response syndrome. PLoS One 12:e0177450. doi: 10.1371/journal.pone.0177450
137. Sato, M., Miyazaki, T., Nagaya, T., Murata, Y., Ida, N., Maeda, K., et al. (1996). Antioxidants inhibit tumor necrosis factor-alpha mediated stimulation of interleukin-8, monocyte chemoattractant protein-1, and collagenase expression in cultured human synovial cells. J. Rheumatol. 23, 432-438
138. Shen, M., Hu, P., Donskov, F., Wang, G., Liu, Q., and Du, J. (2014). Tumor-associated neutrophils as a new prognostic factor in cancer: a systematic review and meta-analysis. PLoS One 9:e98259. doi: 10.1371/journal.pone.0098259
139. Sinden, N. J., Baker, M. J., Smith, D. J., Kreft, J. U., Dafforn, T. R., and Stockley, R. A. (2015). Alpha-1-antitrypsin variants and the proteinase/antiproteinase imbalance in chronic obstructive pulmonary disease. Am. J. Physiol. Lung Cell Mol. Physiol. 308, L179-L190. doi: 10.1152/ajplung.00179.2014
140. Soehnlein, O., Steffens, S., Hidalgo, A., and Weber, C. (2017). Neutrophils as protagonists and targets in chronic inflammation. Nat. Rev. Immunol. 17, 248-261. doi: 10.1038/nri.2017.10
141. Spencer, L. T., Paone, G., Krein, P. M., Rouhani, F. N., Rivera-Nieves, J., and Brantly, M. L. (2004). Role of human neutrophil peptides in lung inflammation associated with alpha1-antitrypsin deficiency. Am. J. Physiol. Lung Cell Mol. Physiol. 286, L514-L520. doi: 10.1152/ajplung.00099.2003
142. Sperling, R. I. (1998). The effects of dietary n-3 polyunsaturated fatty acids on neutrophils. Proc. Nutr. Soc. 57, 527-534. doi: 10.1079/PNS19980077
143. Spriggs, D. R., Sherman, M. L., Imamura, K., Mohri, M., Rodriguez, C., Robbins, G., et al. (1990). Phospholipase A2 activation and autoinduction of tumor necrosis factor gene expression by tumor necrosis factor. Cancer Res. 50, 7101-7107
144. Subramaniyam, D., Zhou, H., Liang, M., Welte, T., Mahadeva, R., and Janciauskiene, S. (2010). Cholesterol rich lipid raft microdomains are gateway for acute phase protein, SERPINA1. Int. J. Biochem. Cell Biol. 42, 1562-1570. doi: 10.1016/j.biocel.2010.06.009
145. Sun, Z., and Yang, P. (2004). Role of imbalance between neutrophil elastase and alpha 1-antitrypsin in cancer development and progression. Lancet Oncol. 5, 182-190. doi: 10.1016/S1470-2045(04)01414-7
146. Taggart, C., Cervantes-Laurean, D., Kim, G., McElvaney, N. G., Wehr, N., Moss, J., et al. (2000). Oxidation of either methionine 351 or methionine 358 in alpha 1-antitrypsin causes loss of anti-neutrophil elastase activity. J. Biol. Chem. 275, 27258-27265. doi: 10.1074/jbc. M004850200
147. Tamassia, N., Zimmermann, M., and Cassatella, M. A. (2012). An additional piece in the puzzle of neutrophil-derived IL-1beta: the NLRP3 inflammasome. Eur. J. Immunol. 42, 565-568. doi: 10.1002/eji.201242399
148. Tan, L., Dickens, J. A., Demeo, D. L., Miranda, E., Perez, J., Rashid, S. T., et al. (2014). Circulating polymers in alpha1-antitrypsin deficiency. Eur. Respir. J. 43, 1501-1504. doi: 10.1183/09031936.00111213
149. Tilg, H., Vannier, E., Vachino, G., Dinarello, C. A., and Mier, J. W. (1993). Antiinflammatory properties of hepatic acute phase proteins: preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1 beta synthesis by human peripheral blood mononuclear cells. J. Exp. Med. 178, 1629-1636. doi: 10.1084/jem.178.5.1629
150. Tiriveedhi, V., Banan, B., Deepti, S., Nataraju, A., Hachem, R., Trulock, E., et al. (2014). Role of defensins in the pathogenesis of chronic lung allograft rejection. Hum. Immunol. 75, 370-377. doi: 10.1016/j.humimm.2013.12.014
151. Tkalcevic, J., Novelli, M., Phylactides, M., Iredale, J. P., Segal, A. W., and Roes, J. (2000). Impaired immunity and enhanced resistance to endotoxin in the absence of neutrophil elastase and cathepsin G. Immunity 12, 201-210. doi: 10.1016/S1074-7613(00)80173-9
152. Ueda, M., Mashiba, S., and Uchida, K. (2002). Evaluation of oxidized alpha-1-antitrypsin in blood as an oxidative stress marker using anti-oxidative alpha1-AT monoclonal antibody. Clin. Chim. Acta 317, 125-131. doi: 10.1016/S0009-8981(01)00765-3
153. Van Wetering, S., Mannesse-Lazeroms, S. P., Van Sterkenburg, M. A., Daha, M. R., Dijkman, J. H., and Hiemstra, P. S. (1997). Effect of defensins on interleukin-8 synthesis in airway epithelial cells. Am. J. Physiol. 272, L888-L896. doi: 10.1152/ajplung.1997.272.5.L888
154. van Wetering, S., Mannesse-Lazeroms, S. P., van Sterkenburg, M. A., and Hiemstra, P. S. (2002). Neutrophil defensins stimulate the release of cytokines by airway epithelial cells: modulation by dexamethasone. Inflamm. Res. 51, 8-15. doi: 10.1007/PL00000282
155. van Wetering, S., Sterk, P. J., Rabe, K. F., and Hiemstra, P. S. (1999). Defensins: key players or bystanders in infection, injury, and repair in the lung? J. Allergy Clin. Immunol. 104, 1131-1138. doi: 10.1016/S0091-6749(99)70004-7
156. Wang, Y., Xiao, Y., Zhong, L., Ye, D., Zhang, J., Tu, Y., et al. (2014). Increased neutrophil elastase and proteinase 3 and augmented NETosis are closely associated with beta-cell autoimmunity in patients with type 1 diabetes. Diabetes Metab. Res. Rev. 63, 4239-4248. doi: 10.2337/db14-0480
157. Waugh, D. J., and Wilson, C. (2008). The interleukin-8 pathway in cancer. Clin. Cancer Res. 14, 6735-6741. doi: 10.1158/1078-0432.CCR-07-4843
158. Wencker, M., and Brantly, M. L. (2005). Cytotoxic concentrations of alpha-defensins in the lungs of individuals with alpha 1-antitrypsin deficiency and moderate to severe lung disease. Cytokine 32, 1-6. doi: 10.1016/j.cyto.2005.06.003
159. Wewers, M. D., Casolaro, M. A., Sellers, S. E., Swayze, S. C., McPhaul, K. M., Wittes, J. T., et al. (1987). Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema. N. Engl. J. Med. 316, 1055-1062. doi: 10.1056/NEJM198704233161704
160. Wiemer, A. J., Lokuta, M. A., Surfus, J. C., Wernimont, S. A., and Huttenlocher, A. (2010). Calpain inhibition impairs TNF-alpha-mediated neutrophil adhesion, arrest and oxidative burst. Mol. Immunol. 47, 894-902. doi: 10.1016/j.molimm.2009.10.002
161. Woolhouse, I. S., Bayley, D. L., and Stockley, R. A. (2002). Sputum chemotactic activity in chronic obstructive pulmonary disease: effect of alpha(1)-antitrypsin deficiency and the role of leukotriene B(4) and interleukin 8. Thorax 57, 709-714. doi: 10.1136/thorax.57.8.709
162. Xu, Y., Zhang, J., Han, J., Pan, X., Cao, Y., Guo, H., et al. (2012). Curcumin inhibits tumor proliferation induced by neutrophil elastase through the upregulation of alpha1-antitrypsin in lung cancer. Mol. Oncol. 6, 405-417. doi: 10.1016/j.molonc.2012.03.005
163. Ying, Q. L., and Simon, S. R. (2000). DNA from bronchial secretions modulates elastase inhibition by alpha(1)-proteinase inhibitor and oxidized secretory leukoprotease inhibitor. Am. J. Respir. Cell Mol. Biol. 23, 506-513. doi: 10.1165/ajrcmb.23.4.3939
164. Yusen, R. D., Christie, J. D., Edwards, L. B., Kucheryavaya, A. Y., Benden, C., Dipchand, A. I., et al. (2013). The Registry of the International Society for Heart and Lung Transplantation: Thirtieth Adult Lung and Heart-Lung Transplant Report-2013; focus theme: age. J. Heart Lung Transplant. 32, 965-978. doi: 10.1016/j.healun.2013.08.007
165. Zelvyte, I., Stevens, T., Westin, U., and Janciauskiene, S. (2004a). Alpha1-antitrypsin and its C-terminal fragment attenuate effects of degranulated neutrophil-conditioned medium on lung cancer HCC cells, in vitro. Cancer Cell Int. 4:7. doi: 10.1186/1475-2867-4-7
166. Zelvyte, I., Wallmark, A., Piitulainen, E., Westin, U., and Janciauskiene, S. (2004b). Increased plasma levels of serine proteinase inhibitors in lung cancer patients. Anticancer Res. 24, 241-247
167. Zhang, Z., Winyard, P. G., Chidwick, K., Murphy, G., Wardell, M., Carrell, R. W., et al. (1994). Proteolysis of human native and oxidised alpha 1-proteinase inhibitor by matrilysin and stromelysin. Biochim. Biophys. Acta 1199, 224-228. doi: 10.1016/0304-4165(94)90119-8
168. Zhou, A., Carrell, R. W., and Huntington, J. A. (2001). The serpin inhibitory mechanism is critically dependent on the length of the reactive center loop. J. Biol. Chem. 276, 27541-27547. doi: 10.1074/jbc. M102594200
169. Zuo, L., Pannell, B. K., Zhou, T., and Chuang, C. C. (2016). Historical role of alpha-1-antitrypsin deficiency in respiratory and hepatic complications. Gene 589, 118-122. doi: 10.1016/j.gene.2016.01.004